Invesaro

Stocks CRUS Financial statements

Financial statements

CIRRUS LOGIC, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CIRRUS LOGIC, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue1,5391,5321,1861,2811,3691,7811,8981,7891,8961,997
Cost of revenue781771588607662858941873900943
Gross profit7587615976747079249579169961,054
Research and development304366375348343406458426435434
Selling, general and administrative127132127131127151153144151160
Operating expenses441498497501470557708573586594
Operating income317262101173237366249343410460
Interest expense3.61.151.061.061.060.950.90.920.90.9
Other non-operating income-0.08-0.97-0.22-1.622.841.71-3.38-0.111.47-0.49
Pre-tax income31526593.7181245369255364445497
Income tax53.81033.7521.827.942.37889.411382.3
Net income26116290159217326177275332414
EBITDA380344181242284428320392461513
EPS, basic4.122.551.502.743.745.703.185.066.248.10
EPS, diluted3.922.461.462.643.625.523.094.906.007.85
Shares, basic (weighted)63.363.460.158.358.157.355.654.353.151.1
Shares, diluted (weighted)66.66661.660.560.159.157.25655.252.8

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents351236216292442370446503540801
Short-term investments99.826.470.22255.710.6
Receivables120101121154109240150162216220
Inventory168206165147173138233227299241
Other current assets12.113.922.411.825.140.15755.228.122.7
Total current assets7766146256508438401,0181,1061,2401,434
Property, plant and equipment168191186158155157163170160144
Lease right-of-use assets141134171128138127121
Goodwill287289286287288436436436436436
Intangible assets13511267.834.42215838.929.627.520.7
Long-term investments017215928431363.7
Other non-current assets14.637.819.727.867.391.673.768.634.718.4
Total assets1,4131,4301,3531,5931,8312,1232,0642,2322,3272,489
Accounts payable73.869.948.478.410311581.555.563.280.6
Accrued liabilities40.235.729.342.454.865.350.647.652.152.7
Total current liabilities144140116159214265216186195195
Lease liabilities129128163123135122114
Other non-current liabilities3.687.669.89013.61.130.510
Total liabilities262268212363442524406415378361
Paid-in capital1,2591,3121,3641,4351,4991,5781,6701,7611,8601,946
Retained earnings-107-139-222-202-11323.4-9.3258.990.4185
Other comprehensive income-0.57-11.4-1.07-3.472.88-2.05-2.54-2.6-1.18-2.84
Shareholders' equity1,1521,1621,1401,2301,3891,6001,6581,8171,9492,128
Total equity1,1521,1621,1401,2301,3891,6001,6581,8171,9492,128
Total liabilities and equity1,4131,4301,3531,5931,8312,1232,0642,2322,3272,489
Shares outstanding64.3625958.257.756.655.153.552.350.6

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income26116290159217326177275332414
Depreciation and amortization63.481.479.868.247.162.171.248.35152.3
Stock-based compensation39.648.749.753.856.866.481.689.384.181.8
Deferred income tax10.911.61.72-5.89-5.58-15-34.5-13.4-0.1-1.13
Change in receivables-31.419.2-14.3-33.145.3-12589.8-12.8-53.5-4.14
Change in inventory-25.9-37.940.617.8-26.542.5-956.2-71.858.2
Change in payables1.770.14-2227.621.110.5-34.3-23.99.1517.5
Cash from operations370319207296349125340422444651
Capital expenditures-41.8-55.2-31.6-15.7-18.3-26.1-35.1-37.7-22.8-14
Acquisitions0000-27700
Purchases of investments-231-238-98.9-249-226-83-15.3-162-131-208
Cash from investing-69.9-185-54.7-100-77.7-18.4-33.3-163-124-75.1
Stock issued16.54.421.6218.67.1313.210.13.3315.43.87
Share buybacks-15.4-176-160-120-110-168-191-186-261-280
Cash from financing-118-250-171-120-121-179-230-202-283-314
Net change in cash182-116-19.475.9150-72.4765736.9261
Free cash flow32826417528033198.6304384422637
Interest paid2.950.840.610.460.610.570.540.660.40.53
Income taxes paid834.420.622.32935.79243.451.749.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 26, 2026; growth uses fiscal years. Valuation uses the share price of $120.17 on November 10, 2026.

Profitability

MetricValueHow it is calculated
Gross margin53.1%Gross profit / revenue.
Operating margin22.5%Operating income / revenue.
EBITDA margin25.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin24.4%Pre-tax income / revenue.
Net margin20.2%Net income / revenue.
FCF margin25.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin27.2%Cash from operations / revenue.
Effective tax rate17.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)18.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)16.0%Net income / average total assets.
Return on invested capital (ROIC)25.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue22.4%Research and development expense / revenue.
SG&A / revenue8.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue3.9%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.5%Capital expenditures / revenue.
D&A / revenue2.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y5.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y7.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y5.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y3.3%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y8.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y12.2%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y22.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y14.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y11.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y17.0%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y12.5%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y25.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y32.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y13.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y30.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y36.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y16.7%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y46.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y24.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y13.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y51.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y27.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y14.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y9.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y8.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y8.9%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y7.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y6.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y6.3%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-4.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio6.41xCurrent assets / current liabilities.
Quick ratio4.75x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio3.15x(Cash + short-term investments) / current liabilities.
Liabilities / assets15.3%Total liabilities / total assets.
Interest coverage452xOperating income / interest expense.
Working capital$1.24BCurrent assets - current liabilities.
Goodwill and intangibles / assets17.5%(Goodwill + intangible assets) / total assets.
Tangible book value$1.74BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.79xRevenue / average total assets.
Fixed asset turnover13.5xRevenue / average property, plant and equipment.
Inventory turnover3.54xCost of revenue / average inventory.
Days inventory103 days365 x average inventory / cost of revenue.
Receivables turnover5.60xRevenue / average receivables.
Days sales outstanding65 days365 x average receivables / revenue.
Days payables40 days365 x average accounts payable / cost of revenue.
Cash conversion cycle129 daysDays inventory + days sales outstanding - days payables.
FCF conversion127.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow5.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$8.04Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$39.79Revenue / diluted weighted shares.
FCF per share$10.22Free cash flow / diluted weighted shares.
Operating cash flow per share$10.83Cash from operations / diluted weighted shares.
Book value per share$42.58Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$33.77Tangible book value / shares outstanding.
Cash per share$13.99(Cash + short-term investments) / shares outstanding.
Buybacks / FCF57.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$6.02BShare price x shares outstanding.
Enterprise value$5.30BMarket cap + total debt - cash - short-term investments.
P/E14.6xMarket cap / net income. Only when net income is positive.
P/S2.94xMarket cap / revenue.
P/B2.75xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book3.46xMarket cap / tangible book value, when positive.
P/FCF11.4xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF10.8xMarket cap / cash from operations, when positive.
EV/Sales2.59xEnterprise value / revenue.
EV/EBIT11.5xEnterprise value / operating income, when both are positive.
EV/EBITDA10.3xEnterprise value / EBITDA, when both are positive.
EV/FCF10.1xEnterprise value / free cash flow, when both are positive.
FCF yield8.7%Free cash flow / market cap.
Earnings yield6.9%Net income / market cap (the inverse of P/E).
Shareholder yield5.0%(Dividends paid + share buybacks) / market cap.
PEG0.40xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was CIRRUS LOGIC, INC.'s revenue in fiscal 2026?

CIRRUS LOGIC, INC. reported revenue of $2.00B for fiscal 2026, 5.3% higher than the year before.

Was CIRRUS LOGIC, INC. profitable in fiscal 2026?

Yes. Net income was $414.4M, a net margin of 20.7%.

How much free cash flow did CIRRUS LOGIC, INC. generate in fiscal 2026?

Cash from operations of $650.6M minus capital expenditures of $14.0M left free cash flow of $636.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CIRRUS LOGIC, INC.